Inventor · disambiguated record
John Davis
Also filed as: DAVIS JOHN · DAVIS JOHN B · DAVIS JOHN BERESFORD
3 granted patents·8 pending applications·106 citations·filing 1998–2023
64Inventor score
Top patents by PatentIndex Score
11 records- 0188US6239267B1VANILREP1 polynucleotides and VANILREP1 polypeptidesSMITHKLINE BEECHAM PLC·Filed 1998·Granted May 29, 2001·106 cites·6 claims
- 0265US2025249117A1Dosing of muscle targeting complexes for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0360US2025018050A1Dosing of muscle targeting complexes for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0451US2007161560A1Use of vanilloid 4 receptor and antagonists or agonists thereof for treating diseases associated with painSMITHKLINE BEECHAM PLC·Filed 2006·Application pending·0 cites
- 0549US2006205641A1VANILREP4 polypeptides and VANILREP4 polynucleotidesSMITHKLINE BEECHAM PLC·Filed 2003·Application pending·0 cites
- 0648US7390817B2Combinations of a vanilloid antagonist and an NSAID for the treatment of painGLAXO GROUP LTD·Filed 2003·Granted Jun 24, 2008·0 cites·2 claims
- 0745US2021139573A1Dosing regimens for treating or preventing c5-associated diseasesREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 0842US11904020B2Bicyclic peptide ligands specific for TREM2BICYCLE TX LTD·Filed 2022·Granted Feb 20, 2024·0 cites·12 claims
- 0942US2005239846A1Use of vanilloid receptor antagonists for the treatment of painDAVIS JOHN B·Filed 2003·Application pending·0 cites
- 1038US2001047090A1VANILREP1 polynucleotides and VANILREP1 polypeptidesFiled 2001·Application pending·0 cites
- 1134US2004198649A1Human vanilloid receptor geneFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →